Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
These encouraging results do not apply, however, to people who remain undiagnosed.
Having trouble adhering to your medications? There are solutions to the problem.
People who started treatment on the same day as their HIV diagnosis achieved an undetectable viral load sooner.
The updates include new information on optimizing therapy, dealing with virological failure and managing opportunistic infections.
Right now, it typically takes six years after an HIV drug is approved to obtain data for pregnant people.
Pioneering HIV doctor Paul Volberding and veteran activist Gregg Gonsalves reflect on the legacy of AIDS and its implications for COVID-19.
The new numbers are encouraging but Black and Latino people continue to be disproportionately affected by HIV.
The COVID-19 pandemic has profoundly disrupted almost every aspect of the battle against HIV.
Stroke is the number one killer of Americans—and nearly twice as common in Black Americans—but the effect of viral load hasn’t been clea...
HIV treatment usually requires daily pills, but longer-acting regimens are gaining ground.
However, it’s still unclear whether Undetectable = Untransmittable extends to breastmilk.
A 30-year retrospective review of abnormalities among infants born to women using antiretrovirals shows low, consistent levels.
At the current pace, only about 20% of the world’s population will be vaccinated by the end of 2021.
The woman has had an undetectable viral load and a normal CD4 count for more than 12 years after stopping antiretroviral therapy.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.
A new long-acting injectables HIV drug shows promise in monkey study.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.